The Targeted Therapy Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Targeted Therapy Market?
The market size of the targeted therapy has seen significant expansion in the past few years. It is anticipated to increase from $103.84 billion in 2024 to $111.47 billion in 2025, with a compound annual growth rate (CAGR) of 7.3%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Targeted Therapy Industry?
The Targeted Therapy Global Market Report 2025 projects that by 2029, the market size will be $151.48 billion with a compound annual growth rate (CAGR) of 8.0%.
Download Your Free Sample of the 2025 Targeted Therapy Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Targeted Therapy Market?
The key drivers in the targeted therapy market are:
• Expansion of oncology research and rising demand for precision medicine
• Emergence of immunotherapies and increasing investment in biopharmaceuticals
• Growing patient awareness and advocacy
• Integration of artificial intelligence in drug discovery and expansion of companion diagnostics.
Global Market Segmentation: Identifying Major Targeted Therapy Industry Segments
The targeted therapy market covered in this report is segmented –
1) By Type: Small Molecule Medicines, Monoclonal Antibodies
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
3) By Application: Breast Cancer, Colorectal Cancer, Leukemia, Lung Cancer, Lymphoma, Renal Cancer, Other Applications
Pre-order the 2025 Targeted Therapy Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Targeted Therapy Market?
The key trends in the targeted therapy market are:
• Integration of artificial intelligence in drug discovery is a key emerging trend.
• Patient advocacy and involvement in treatment decisions is shaping the future of the market.
• Expansion of companion diagnostics is becoming a significant trend.
• Regulatory support for expedited approvals and increased investment in biotechnology and pharmaceuticals are influencing the market.
Who Are the Top Competitors & Leading Players in the Targeted Therapy Market?
Major companies in the targeted therapy market are:
• Pfizer Inc.
• Johnson & Johnson
• F. Hoffmann-La Roche Ltd
• Merck & Co Inc.
• AbbVie Inc.
• Bayer AG
• Novartis AG
• Sanofi SA
• Bristol Myers Squibb
• AstraZeneca
• GlaxoSmithKline plc
• Takeda Pharmaceutical Company Limited
• Eli Lilly and Company
• Gilead Sciences Inc.
• Amgen Inc.
• Genmab A/S
• Regeneron Pharmaceuticals Inc.
• Biogen Inc.
• Vertex Pharmaceuticals Incorporated
• Agilent Technologies Inc.
• Illumina Inc.
• Incyte Corporation
• Sysmex Corporation
• Exact Sciences Corporation
• Seagen Inc.
• Exelixis Inc.
• Seattle Genetics Inc.
• Genentech Inc.
• Daiichi Sankyo Company Limited
Regional Dominance: Which Area Leads the Global Template Market?
North America was the largest region in the targeted therapy market in 2024
